nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—CHRNA2—Carbachol—glaucoma	0.458	0.565	CbGbCtD
Vecuronium—SLC22A1—Latanoprost—glaucoma	0.218	0.269	CbGbCtD
Vecuronium—SLC22A1—Clonidine—glaucoma	0.0808	0.0996	CbGbCtD
Vecuronium—ABCB1—Timolol—glaucoma	0.0291	0.0359	CbGbCtD
Vecuronium—ABCB1—Clonidine—glaucoma	0.0247	0.0305	CbGbCtD
Vecuronium—Paralysis flaccid—Methazolamide—glaucoma	0.0174	0.0919	CcSEcCtD
Vecuronium—Paralysis flaccid—Acetazolamide—glaucoma	0.012	0.0636	CcSEcCtD
Vecuronium—Redness—Echothiophate—glaucoma	0.00751	0.0397	CcSEcCtD
Vecuronium—Respiratory failure—Carteolol—glaucoma	0.00321	0.017	CcSEcCtD
Vecuronium—Respiratory failure—Levobunolol—glaucoma	0.00303	0.016	CcSEcCtD
Vecuronium—Redness—Dorzolamide—glaucoma	0.00268	0.0142	CcSEcCtD
Vecuronium—Pulmonary function test decreased—Brimonidine—glaucoma	0.00252	0.0133	CcSEcCtD
Vecuronium—Respiratory depression—Brimonidine—glaucoma	0.00252	0.0133	CcSEcCtD
Vecuronium—Injection site pain—Acetazolamide—glaucoma	0.00242	0.0128	CcSEcCtD
Vecuronium—Rash erythematous—Dorzolamide—glaucoma	0.00236	0.0125	CcSEcCtD
Vecuronium—Apnoea—Brimonidine—glaucoma	0.00224	0.0118	CcSEcCtD
Vecuronium—Erythema—Echothiophate—glaucoma	0.00222	0.0117	CcSEcCtD
Vecuronium—Tachycardia—Dipivefrin—glaucoma	0.00211	0.0111	CcSEcCtD
Vecuronium—Bronchospasm—Carteolol—glaucoma	0.00194	0.0103	CcSEcCtD
Vecuronium—Respiratory failure—Brimonidine—glaucoma	0.00193	0.0102	CcSEcCtD
Vecuronium—Respiratory failure—Dorzolamide—glaucoma	0.00184	0.00975	CcSEcCtD
Vecuronium—Bronchospasm—Levobunolol—glaucoma	0.00184	0.00972	CcSEcCtD
Vecuronium—Hypersensitivity—Dipivefrin—glaucoma	0.00159	0.00841	CcSEcCtD
Vecuronium—Rash erythematous—Betaxolol—glaucoma	0.00155	0.00821	CcSEcCtD
Vecuronium—Face oedema—Apraclonidine—glaucoma	0.00155	0.00818	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Acetazolamide—glaucoma	0.00148	0.00783	CcSEcCtD
Vecuronium—Flushing—Carbachol—glaucoma	0.00141	0.00745	CcSEcCtD
Vecuronium—Respiratory failure—Clonidine—glaucoma	0.00139	0.00736	CcSEcCtD
Vecuronium—Connective tissue disorder—Latanoprost—glaucoma	0.00136	0.00721	CcSEcCtD
Vecuronium—Face oedema—Brimonidine—glaucoma	0.00133	0.00702	CcSEcCtD
Vecuronium—Rash erythematous—Timolol—glaucoma	0.00127	0.00671	CcSEcCtD
Vecuronium—Mediastinal disorder—Latanoprost—glaucoma	0.00125	0.00661	CcSEcCtD
Vecuronium—Respiratory failure—Betaxolol—glaucoma	0.00121	0.0064	CcSEcCtD
Vecuronium—Erythema—Latanoprost—glaucoma	0.00121	0.00638	CcSEcCtD
Vecuronium—Face oedema—Pilocarpine—glaucoma	0.0012	0.00634	CcSEcCtD
Vecuronium—Bronchospasm—Dorzolamide—glaucoma	0.00112	0.00591	CcSEcCtD
Vecuronium—Shock—Carteolol—glaucoma	0.00111	0.00585	CcSEcCtD
Vecuronium—Muscular weakness—Pilocarpine—glaucoma	0.00109	0.00579	CcSEcCtD
Vecuronium—Shock—Carbachol—glaucoma	0.00106	0.00561	CcSEcCtD
Vecuronium—Connective tissue disorder—Bimatoprost—glaucoma	0.00106	0.00559	CcSEcCtD
Vecuronium—Bronchospasm—Pilocarpine—glaucoma	0.00106	0.00558	CcSEcCtD
Vecuronium—Hypotension—Carteolol—glaucoma	0.00105	0.00556	CcSEcCtD
Vecuronium—Shock—Levobunolol—glaucoma	0.00105	0.00553	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00102	0.0054	CcSEcCtD
Vecuronium—Anaphylactic shock—Methazolamide—glaucoma	0.00102	0.00538	CcSEcCtD
Vecuronium—Hypotension—Carbachol—glaucoma	0.00101	0.00533	CcSEcCtD
Vecuronium—Angiopathy—Apraclonidine—glaucoma	0.00101	0.00532	CcSEcCtD
Vecuronium—Mediastinal disorder—Apraclonidine—glaucoma	0.000999	0.00528	CcSEcCtD
Vecuronium—Hypotension—Levobunolol—glaucoma	0.000993	0.00525	CcSEcCtD
Vecuronium—Respiratory failure—Timolol—glaucoma	0.000989	0.00523	CcSEcCtD
Vecuronium—Angiopathy—Bimatoprost—glaucoma	0.000975	0.00516	CcSEcCtD
Vecuronium—Mediastinal disorder—Bimatoprost—glaucoma	0.000969	0.00512	CcSEcCtD
Vecuronium—Nervous system disorder—Latanoprost—glaucoma	0.000966	0.00511	CcSEcCtD
Vecuronium—Erythema—Apraclonidine—glaucoma	0.000965	0.0051	CcSEcCtD
Vecuronium—Skin disorder—Latanoprost—glaucoma	0.000957	0.00506	CcSEcCtD
Vecuronium—Erythema—Bimatoprost—glaucoma	0.000936	0.00495	CcSEcCtD
Vecuronium—Flushing—Acetazolamide—glaucoma	0.00092	0.00487	CcSEcCtD
Vecuronium—Hypersensitivity—Metipranolol—glaucoma	0.000894	0.00473	CcSEcCtD
Vecuronium—Connective tissue disorder—Travoprost—glaucoma	0.000889	0.0047	CcSEcCtD
Vecuronium—Flushing—Brimonidine—glaucoma	0.000883	0.00467	CcSEcCtD
Vecuronium—Cardiac disorder—Brimonidine—glaucoma	0.000883	0.00467	CcSEcCtD
Vecuronium—Connective tissue disorder—Brinzolamide—glaucoma	0.000878	0.00464	CcSEcCtD
Vecuronium—Angiopathy—Brimonidine—glaucoma	0.000863	0.00457	CcSEcCtD
Vecuronium—Immune system disorder—Brimonidine—glaucoma	0.00086	0.00455	CcSEcCtD
Vecuronium—Mediastinal disorder—Brimonidine—glaucoma	0.000858	0.00454	CcSEcCtD
Vecuronium—Urticaria—Levobunolol—glaucoma	0.000844	0.00446	CcSEcCtD
Vecuronium—Cardiac disorder—Travoprost—glaucoma	0.00084	0.00444	CcSEcCtD
Vecuronium—Cardiac disorder—Brinzolamide—glaucoma	0.000829	0.00439	CcSEcCtD
Vecuronium—Erythema—Brimonidine—glaucoma	0.000828	0.00438	CcSEcCtD
Vecuronium—Hypersensitivity—Carteolol—glaucoma	0.000828	0.00438	CcSEcCtD
Vecuronium—Angiopathy—Travoprost—glaucoma	0.000821	0.00434	CcSEcCtD
Vecuronium—Immune system disorder—Travoprost—glaucoma	0.000817	0.00432	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000816	0.00432	CcSEcCtD
Vecuronium—Mediastinal disorder—Travoprost—glaucoma	0.000816	0.00431	CcSEcCtD
Vecuronium—Angiopathy—Brinzolamide—glaucoma	0.000811	0.00429	CcSEcCtD
Vecuronium—Urticaria—Methazolamide—glaucoma	0.000809	0.00428	CcSEcCtD
Vecuronium—Immune system disorder—Brinzolamide—glaucoma	0.000807	0.00427	CcSEcCtD
Vecuronium—Mediastinal disorder—Brinzolamide—glaucoma	0.000805	0.00426	CcSEcCtD
Vecuronium—Flushing—Pilocarpine—glaucoma	0.000797	0.00422	CcSEcCtD
Vecuronium—Erythema—Dorzolamide—glaucoma	0.000791	0.00418	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000791	0.00418	CcSEcCtD
Vecuronium—Erythema—Travoprost—glaucoma	0.000788	0.00417	CcSEcCtD
Vecuronium—Hypersensitivity—Levobunolol—glaucoma	0.000783	0.00414	CcSEcCtD
Vecuronium—Erythema—Brinzolamide—glaucoma	0.000778	0.00411	CcSEcCtD
Vecuronium—Nervous system disorder—Apraclonidine—glaucoma	0.000772	0.00409	CcSEcCtD
Vecuronium—Rash—Metipranolol—glaucoma	0.000765	0.00405	CcSEcCtD
Vecuronium—Skin disorder—Apraclonidine—glaucoma	0.000765	0.00405	CcSEcCtD
Vecuronium—Dermatitis—Metipranolol—glaucoma	0.000764	0.00404	CcSEcCtD
Vecuronium—Nervous system disorder—Bimatoprost—glaucoma	0.000749	0.00396	CcSEcCtD
Vecuronium—Skin disorder—Bimatoprost—glaucoma	0.000742	0.00392	CcSEcCtD
Vecuronium—Bronchospasm—Betaxolol—glaucoma	0.000734	0.00388	CcSEcCtD
Vecuronium—Angioedema—Dorzolamide—glaucoma	0.000723	0.00382	CcSEcCtD
Vecuronium—Anaphylactic shock—Acetazolamide—glaucoma	0.000705	0.00373	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.0007	0.0037	CcSEcCtD
Vecuronium—Rash—Diclofenamide—glaucoma	0.000697	0.00369	CcSEcCtD
Vecuronium—Shock—Acetazolamide—glaucoma	0.000693	0.00367	CcSEcCtD
Vecuronium—Rash—Carbachol—glaucoma	0.00068	0.0036	CcSEcCtD
Vecuronium—Dermatitis—Carbachol—glaucoma	0.00068	0.00359	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000666	0.00352	CcSEcCtD
Vecuronium—Shock—Brimonidine—glaucoma	0.000665	0.00352	CcSEcCtD
Vecuronium—Nervous system disorder—Brimonidine—glaucoma	0.000663	0.00351	CcSEcCtD
Vecuronium—Tachycardia—Brimonidine—glaucoma	0.00066	0.00349	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000658	0.00348	CcSEcCtD
Vecuronium—Skin disorder—Brimonidine—glaucoma	0.000657	0.00347	CcSEcCtD
Vecuronium—Anaphylactic shock—Dorzolamide—glaucoma	0.000646	0.00342	CcSEcCtD
Vecuronium—Rash—Methazolamide—glaucoma	0.000642	0.00339	CcSEcCtD
Vecuronium—Dermatitis—Methazolamide—glaucoma	0.000641	0.00339	CcSEcCtD
Vecuronium—Cardiac disorder—Clonidine—glaucoma	0.000637	0.00337	CcSEcCtD
Vecuronium—Shock—Dorzolamide—glaucoma	0.000635	0.00336	CcSEcCtD
Vecuronium—Hypotension—Brimonidine—glaucoma	0.000632	0.00334	CcSEcCtD
Vecuronium—Nervous system disorder—Travoprost—glaucoma	0.000631	0.00333	CcSEcCtD
Vecuronium—Tachycardia—Travoprost—glaucoma	0.000628	0.00332	CcSEcCtD
Vecuronium—Skin disorder—Travoprost—glaucoma	0.000625	0.0033	CcSEcCtD
Vecuronium—Nervous system disorder—Brinzolamide—glaucoma	0.000623	0.00329	CcSEcCtD
Vecuronium—Angiopathy—Clonidine—glaucoma	0.000622	0.00329	CcSEcCtD
Vecuronium—Rash—Latanoprost—glaucoma	0.000621	0.00329	CcSEcCtD
Vecuronium—Dermatitis—Latanoprost—glaucoma	0.000621	0.00328	CcSEcCtD
Vecuronium—Tachycardia—Brinzolamide—glaucoma	0.00062	0.00328	CcSEcCtD
Vecuronium—Mediastinal disorder—Clonidine—glaucoma	0.000618	0.00327	CcSEcCtD
Vecuronium—Skin disorder—Brinzolamide—glaucoma	0.000617	0.00326	CcSEcCtD
Vecuronium—Hypotension—Dorzolamide—glaucoma	0.000603	0.00319	CcSEcCtD
Vecuronium—Hypotension—Travoprost—glaucoma	0.000601	0.00318	CcSEcCtD
Vecuronium—Shock—Pilocarpine—glaucoma	0.0006	0.00318	CcSEcCtD
Vecuronium—Bronchospasm—Timolol—glaucoma	0.000599	0.00317	CcSEcCtD
Vecuronium—Erythema—Clonidine—glaucoma	0.000597	0.00316	CcSEcCtD
Vecuronium—Tachycardia—Pilocarpine—glaucoma	0.000596	0.00315	CcSEcCtD
Vecuronium—Hypotension—Brinzolamide—glaucoma	0.000593	0.00314	CcSEcCtD
Vecuronium—Hypersensitivity—Apraclonidine—glaucoma	0.00058	0.00307	CcSEcCtD
Vecuronium—Hypotension—Pilocarpine—glaucoma	0.00057	0.00302	CcSEcCtD
Vecuronium—Urticaria—Acetazolamide—glaucoma	0.00056	0.00296	CcSEcCtD
Vecuronium—Cardiac disorder—Betaxolol—glaucoma	0.000554	0.00293	CcSEcCtD
Vecuronium—Flushing—Betaxolol—glaucoma	0.000554	0.00293	CcSEcCtD
Vecuronium—Angioedema—Clonidine—glaucoma	0.000546	0.00289	CcSEcCtD
Vecuronium—Angiopathy—Betaxolol—glaucoma	0.000542	0.00287	CcSEcCtD
Vecuronium—Immune system disorder—Betaxolol—glaucoma	0.000539	0.00285	CcSEcCtD
Vecuronium—Mediastinal disorder—Betaxolol—glaucoma	0.000538	0.00285	CcSEcCtD
Vecuronium—Erythema—Betaxolol—glaucoma	0.00052	0.00275	CcSEcCtD
Vecuronium—Urticaria—Dorzolamide—glaucoma	0.000513	0.00271	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000505	0.00267	CcSEcCtD
Vecuronium—Urticaria—Brinzolamide—glaucoma	0.000504	0.00267	CcSEcCtD
Vecuronium—Hypersensitivity—Brimonidine—glaucoma	0.000498	0.00263	CcSEcCtD
Vecuronium—Dermatitis—Apraclonidine—glaucoma	0.000496	0.00262	CcSEcCtD
Vecuronium—Rash—Bimatoprost—glaucoma	0.000481	0.00255	CcSEcCtD
Vecuronium—Dermatitis—Bimatoprost—glaucoma	0.000481	0.00254	CcSEcCtD
Vecuronium—Shock—Clonidine—glaucoma	0.000479	0.00254	CcSEcCtD
Vecuronium—Connective tissue disorder—Timolol—glaucoma	0.000479	0.00254	CcSEcCtD
Vecuronium—Nervous system disorder—Clonidine—glaucoma	0.000478	0.00253	CcSEcCtD
Vecuronium—Hypersensitivity—Dorzolamide—glaucoma	0.000476	0.00252	CcSEcCtD
Vecuronium—Tachycardia—Clonidine—glaucoma	0.000476	0.00252	CcSEcCtD
Vecuronium—Hypersensitivity—Travoprost—glaucoma	0.000474	0.00251	CcSEcCtD
Vecuronium—Skin disorder—Clonidine—glaucoma	0.000473	0.0025	CcSEcCtD
Vecuronium—Hypersensitivity—Brinzolamide—glaucoma	0.000468	0.00247	CcSEcCtD
Vecuronium—Hypotension—Clonidine—glaucoma	0.000455	0.00241	CcSEcCtD
Vecuronium—Cardiac disorder—Timolol—glaucoma	0.000453	0.00239	CcSEcCtD
Vecuronium—Hypersensitivity—Pilocarpine—glaucoma	0.00045	0.00238	CcSEcCtD
Vecuronium—Angiopathy—Timolol—glaucoma	0.000443	0.00234	CcSEcCtD
Vecuronium—Immune system disorder—Timolol—glaucoma	0.000441	0.00233	CcSEcCtD
Vecuronium—Mediastinal disorder—Timolol—glaucoma	0.00044	0.00233	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000439	0.00232	CcSEcCtD
Vecuronium—Rash—Brimonidine—glaucoma	0.000426	0.00225	CcSEcCtD
Vecuronium—Dermatitis—Brimonidine—glaucoma	0.000426	0.00225	CcSEcCtD
Vecuronium—Erythema—Timolol—glaucoma	0.000425	0.00225	CcSEcCtD
Vecuronium—Shock—Betaxolol—glaucoma	0.000417	0.00221	CcSEcCtD
Vecuronium—Nervous system disorder—Betaxolol—glaucoma	0.000416	0.0022	CcSEcCtD
Vecuronium—Tachycardia—Betaxolol—glaucoma	0.000414	0.00219	CcSEcCtD
Vecuronium—Skin disorder—Betaxolol—glaucoma	0.000412	0.00218	CcSEcCtD
Vecuronium—Rash—Dorzolamide—glaucoma	0.000407	0.00215	CcSEcCtD
Vecuronium—Dermatitis—Dorzolamide—glaucoma	0.000407	0.00215	CcSEcCtD
Vecuronium—Rash—Travoprost—glaucoma	0.000405	0.00214	CcSEcCtD
Vecuronium—Dermatitis—Travoprost—glaucoma	0.000405	0.00214	CcSEcCtD
Vecuronium—Rash—Brinzolamide—glaucoma	0.0004	0.00212	CcSEcCtD
Vecuronium—Dermatitis—Brinzolamide—glaucoma	0.0004	0.00212	CcSEcCtD
Vecuronium—Hypotension—Betaxolol—glaucoma	0.000396	0.0021	CcSEcCtD
Vecuronium—Angioedema—Timolol—glaucoma	0.000388	0.00205	CcSEcCtD
Vecuronium—Urticaria—Clonidine—glaucoma	0.000387	0.00205	CcSEcCtD
Vecuronium—Rash—Pilocarpine—glaucoma	0.000385	0.00203	CcSEcCtD
Vecuronium—Dermatitis—Pilocarpine—glaucoma	0.000384	0.00203	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000359	0.0019	CcSEcCtD
Vecuronium—Hypersensitivity—Clonidine—glaucoma	0.000359	0.0019	CcSEcCtD
Vecuronium—Anaphylactic shock—Timolol—glaucoma	0.000347	0.00183	CcSEcCtD
Vecuronium—Shock—Timolol—glaucoma	0.000341	0.0018	CcSEcCtD
Vecuronium—Nervous system disorder—Timolol—glaucoma	0.00034	0.0018	CcSEcCtD
Vecuronium—Urticaria—Betaxolol—glaucoma	0.000337	0.00178	CcSEcCtD
Vecuronium—Skin disorder—Timolol—glaucoma	0.000337	0.00178	CcSEcCtD
Vecuronium—Hypotension—Timolol—glaucoma	0.000324	0.00171	CcSEcCtD
Vecuronium—Hypersensitivity—Betaxolol—glaucoma	0.000313	0.00165	CcSEcCtD
Vecuronium—Rash—Clonidine—glaucoma	0.000307	0.00162	CcSEcCtD
Vecuronium—Dermatitis—Clonidine—glaucoma	0.000307	0.00162	CcSEcCtD
Vecuronium—Urticaria—Timolol—glaucoma	0.000275	0.00146	CcSEcCtD
Vecuronium—Rash—Betaxolol—glaucoma	0.000267	0.00141	CcSEcCtD
Vecuronium—Dermatitis—Betaxolol—glaucoma	0.000267	0.00141	CcSEcCtD
Vecuronium—Hypersensitivity—Timolol—glaucoma	0.000255	0.00135	CcSEcCtD
Vecuronium—Rash—Timolol—glaucoma	0.000219	0.00116	CcSEcCtD
Vecuronium—Dermatitis—Timolol—glaucoma	0.000218	0.00115	CcSEcCtD
